VANCOUVER, British Columbia, April 11, 2019 (GLOBE NEWSWIRE) -- FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (FNNZF) a royalty company for the U.S. licensed cannabis industry is pleased to announce the appointment of Harborside’s wholesale and distribution manager Dani Walton to FinCanna’s Board of Advisors.
Dani has traveled the world with the executive team of Harborside for more than 10 years, promoting the positive impacts of the cannabis plant. Harborside is considered to be the largest medical cannabis dispensary in California and a model for the U.S. Dani is also developing products for the in house Harborside brands and is well versed in the latest consumer trends, new brands and products, and the evolving science of cannabis medicine. She is also an industry leader in dabbing education, working to enlighten patients and adult-use consumers in the health benefits of this relatively new consumption option. Dani has been featured in Forbes, The Guardian, The Independent and numerous other publications and media outlets.
“We are very pleased to have Dani join our Advisory Board,” said Andriyko Herchak, CEO of Fincanna Capital. “Dani is a recognized industry leader and is privy to the latest methods of consumption on the market, and to the ever advancing state of cannabis medicines. We look forward to the contribution and insight that Dani will bring to FinCanna as we continue to build out our diversified investment portfolio in creating long term sustainable success for our shareholders.”
About FinCanna Capital Corp.
FinCanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry. The Company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage of their total revenues.
FinCanna’s scalable royalty model provides an attractive alternative or complement to debt or equity financing for its investee companies. FinCanna is focused on delivering high-impact returns to its shareholders by way of a strategically diversified investment portfolio.
FinCanna Capital Corp.
Andriyko Herchak, CEO & Director
Cautionary Note Regarding Forward-Looking Statements
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about how the developing U.S. legal regime will impact the cannabis industry. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the CSE listing statement and other reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made, and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.